CNCR vs. IEIH ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to iShares Evolved U.S. Innovative Healthcare ETF (IEIH)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$29.29

Average Daily Volume

6,567

Number of Holdings *

27

* may have additional holdings in another (foreign) market
IEIH

iShares Evolved U.S. Innovative Healthcare ETF

IEIH Description The investment seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$32.94

Average Daily Volume

6,835

Number of Holdings *

246

* may have additional holdings in another (foreign) market
Performance
CNCR IEIH
30 Days -6.41% -0.87%
60 Days -13.12% -5.29%
90 Days -13.70% -3.41%
12 Months 40.14% 20.36%
15 Overlapping Holdings
Grade Symbol Weight in CNCR Weight in IEIH Overlap
F ALLO 4.47% 0.18% 0.18%
F ATRA 2.2% 0.08% 0.08%
F BLUE 2.63% 0.18% 0.18%
B BMY 3.84% 4.76% 3.84%
D FATE 2.91% 0.42% 0.42%
C GILD 4.03% 4.57% 4.03%
F IOVA 2.34% 0.31% 0.31%
B MGNX 5.18% 0.13% 0.13%
F NKTR 4.35% 0.28% 0.28%
C RCUS 3.86% 0.14% 0.14%
C REGN 3.75% 3.27% 3.27%
F REPL 2.53% 0.05% 0.05%
F SRRK 2.6% 0.06% 0.06%
D XNCR 3.67% 0.15% 0.15%
F YMAB 2.03% 0.05% 0.05%
CNCR Overweight 12 Positions Relative to IEIH
Grade Symbol Weight
D BGNE 5.26%
C IMAB 5.14%
D LEGN 3.96%
D ARGX 3.64%
D AZN 3.35%
A BNTX 3.25%
F IGMS 3.21%
D GMAB 3.17%
F MOR 2.97%
D CRSP 2.86%
F ALXO 2.3%
F NKTX 1.66%
CNCR Underweight 231 Positions Relative to IEIH
Grade Symbol Weight
C JNJ -10.07%
C MRK -6.18%
B PFE -5.98%
B ABBV -5.95%
D LLY -5.05%
B AMGN -4.61%
C VRTX -3.49%
C MRNA -3.44%
D BIIB -2.47%
B ZTS -2.27%
B ALXN -1.71%
B HZNP -1.32%
F SGEN -1.31%
F ALNY -1.19%
F BMRN -0.96%
D NVAX -0.68%
C JAZZ -0.68%
F NBIX -0.67%
B UTHR -0.6%
F VTRS -0.55%
F MRTX -0.54%
B IQV -0.53%
D XLRN -0.52%
B EXEL -0.51%
C NVCR -0.5%
B BAX -0.5%
C INCY -0.5%
C CTLT -0.49%
D EXAS -0.46%
F IONS -0.44%
F RARE -0.43%
D ARWR -0.43%
D BHC -0.43%
C HALO -0.43%
D BPMC -0.42%
A CRL -0.4%
B GH -0.39%
B DXCM -0.39%
D ELAN -0.38%
F SRPT -0.38%
D BBIO -0.38%
B RGEN -0.38%
D DNLI -0.33%
F ARNA -0.33%
D SAGE -0.31%
D TGTX -0.3%
A PRAH -0.28%
B TXG -0.28%
C NTLA -0.28%
F INSM -0.27%
B AGIO -0.27%
D KOD -0.23%
D ALLK -0.22%
D APLS -0.22%
F TPTX -0.22%
A COO -0.21%
C OLED -0.21%
D LGND -0.2%
D ALKS -0.2%
F PRGO -0.2%
B RMD -0.2%
F EBS -0.19%
F PTCT -0.19%
F GBT -0.19%
F FOLD -0.19%
F VIR -0.18%
F ACAD -0.18%
F RETA -0.17%
F EDIT -0.16%
D PCRX -0.16%
F CCXI -0.16%
C ABT -0.16%
F ADPT -0.16%
D ITCI -0.16%
D CORT -0.16%
F BHVN -0.16%
C DCPH -0.15%
D KRTX -0.15%
C INSP -0.15%
C BCRX -0.15%
A ABC -0.14%
A PODD -0.14%
A SYNH -0.14%
C RVNC -0.14%
D GKOS -0.14%
F KURA -0.13%
F AXSM -0.13%
D NVRO -0.13%
F INO -0.13%
D NTRA -0.12%
F SRNE -0.12%
D BEAM -0.11%
B DRNA -0.11%
F SGMO -0.11%
B MEDP -0.11%
F FGEN -0.11%
B FPRX -0.11%
C IDXX -0.1%
D ARVN -0.1%
B ISRG -0.1%
A SUPN -0.1%
B IRWD -0.1%
D HAE -0.1%
D IMGN -0.09%
D ALEC -0.09%
F ZGNX -0.09%
B VCEL -0.09%
B PEN -0.09%
C HRTX -0.09%
D OCUL -0.08%
C CYTK -0.08%
F MRSN -0.08%
B NSTG -0.08%
C CDNA -0.08%
D PTGX -0.08%
F MCRB -0.08%
B BIO -0.08%
D TVTX -0.08%
F RGNX -0.07%
A IART -0.07%
B MDGL -0.07%
A LNTH -0.07%
C CDXS -0.07%
F CHRS -0.07%
D SNDX -0.07%
B CARA -0.07%
D RCKT -0.06%
C TBPH -0.06%
C ICUI -0.06%
B PRTA -0.06%
D MYGN -0.06%
C ACRS -0.06%
C RUBY -0.06%
D RDUS -0.06%
C KRYS -0.06%
F OPK -0.06%
D TBIO -0.06%
F KPTI -0.06%
F RYTM -0.06%
D ENDP -0.06%
F CERS -0.06%
D VNDA -0.06%
D OMER -0.05%
C AERI -0.05%
F ESPR -0.05%
C ENTA -0.05%
F KDMN -0.05%
F ARCT -0.05%
D AMRX -0.05%
F EPZM -0.05%
F ICPT -0.05%
C PBH -0.04%
D INVA -0.04%
F STOK -0.04%
F ADVM -0.04%
F ALBO -0.04%
B DVAX -0.04%
A IDCC -0.04%
B ARDX -0.04%
D COLL -0.04%
F CNST -0.04%
F AKBA -0.04%
D ATRS -0.04%
D CRTX -0.04%
F AMPH -0.04%
C CRNX -0.04%
F BTAI -0.04%
D RIGL -0.04%
D EGRX -0.04%
D MEIP -0.04%
C RLMD -0.04%
C GTHX -0.04%
F GOSS -0.03%
D ZIOP -0.03%
F CUE -0.03%
C AGLE -0.03%
F KNSA -0.03%
D CLDX -0.03%
F KALA -0.03%
F VXRT -0.03%
F ATHX -0.03%
F PRVB -0.03%
B ANIK -0.02%
F VKTX -0.02%
F SYRS -0.02%
F MTEM -0.02%
D XENT -0.02%
F PBYI -0.02%
D CLVS -0.02%
F FREQ -0.02%
F ANAB -0.02%
F CBAY -0.02%
F SPPI -0.02%
F AVRO -0.02%
F ATNX -0.02%
B CPRX -0.02%
F FLXN -0.02%
F FIXX -0.02%
D PGEN -0.02%
F URGN -0.02%
D CTMX -0.02%
F APLT -0.02%
D LXRX -0.02%
D AXGN -0.02%
F CALA -0.02%
B PRTK -0.02%
F AGEN -0.02%
C ANIP -0.01%
F TXMD -0.01%
F MNOV -0.01%
F GERN -0.01%
F PIRS -0.01%
D JNCE -0.01%
F TCDA -0.01%
F NXTC -0.01%
F VYGR -0.01%
F LCI -0.01%
D KDNY -0.01%
F GLYC -0.01%
F WVE -0.01%
F CNCE -0.01%
F APRE -0.01%
D ADMS -0.01%
F CRBP -0.01%
F ASMB -0.01%
F LJPC -0.01%
D SLDB -0.01%
F ODT -0.0%
F ABEO -0.0%
F CYCN -0.0%
D ACOR -0.0%
Compare ETFs